PATENT CLAIM ANALYSIS

Application Number: 16358013
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "04400R"]

Abstract:
Provided are therapeutic agents such as double-stranded nucleic acids, termed oligonucleotide decoys, pharmaceutical compositions comprising the same, and related methods of modulating nociceptive signaling, for instance, to prevent and/or treat pain.

Claim (Index 19):
A method for modulating nociceptive signaling in a cell comprising administering to the cell an effective amount of a population of oligonucleotide decoys of  claim 1 .

Metadata:
- Claim Count in Document: 46.0
- Percentile: 99.0
- Lexical Diversity: 1.12121
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15504191', '13048793', '13316321', '14258927', '12119435']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.728270717732708
- 35 USC 102 Novelty (BERT): 0.7790244094002396
- Combined Prediction Score: 0.7333460868994612
- Mean Citation Score: 484.57665599999984
- Max Citation Score: 1020.33746
- Similarity Product: 914.3063196345782

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test